Mariner’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,093
Closed -$521K 3644
2025
Q1
$521K Buy
4,093
+315
+8% +$48.5K ﹤0.01% 2175
2024
Q4
$544K Sell
3,778
-29
-0.8% -$4.16K ﹤0.01% 2129
2024
Q3
$566K Buy
3,807
+106
+3% +$15.2K ﹤0.01% 2026
2024
Q2
$467K Sell
3,701
-530
-13% -$83.1K ﹤0.01% 2098
2024
Q1
$778K Sell
4,231
-19
-0.4% -$3.62K ﹤0.01% 1690
2023
Q4
$764K Buy
4,250
+358
+9% +$55.7K ﹤0.01% 1632
2023
Q3
$619K Sell
3,892
-611
-14% -$99.9K ﹤0.01% 1630
2023
Q2
$637K Buy
4,503
+1,371
+44% +$220K ﹤0.01% 1580
2023
Q1
$528K Sell
3,132
-164
-5% -$29.3K ﹤0.01% 1659
2022
Q4
$558K Buy
3,296
+399
+14% +$72.4K ﹤0.01% 1595
2022
Q3
$542K Buy
+2,897
New +$611K ﹤0.01% 1366

Other funds holding RGEN

Mariner's RGEN Position: Q2 2025 in Review

Mariner sold out of Repligen (RGEN) in Q2 2025, closing a stake of 4,093 shares — an estimated $521K sold.

Mariner first reported a position in RGEN in Q3 2022 and held it in 11 quarters. The position peaked at $778K in Q1 2024. 444 funds tracked by Wall St. Rank hold RGEN as of Q2 2025.

  • Mariner reported no remaining Repligen position as of Q2 2025 after selling out during the quarter.
  • Mariner sold 4,093 Repligen shares in Q2 2025, an estimated $521K.
  • Mariner first reported a position in Repligen in Q3 2022 and held it in 11 quarters.
  • Mariner's Repligen position peaked at $778K in Q1 2024.
  • 444 funds tracked by Wall St. Rank held Repligen as of Q2 2025.

Based on Mariner's 13F filing for Q2 2025, filed 14 Aug 2025.